Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
A role for TNF-α in alveolar macrophage damage-associated molecular pattern release
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee
View: Text | PDF
Research Article Immunology

A role for TNF-α in alveolar macrophage damage-associated molecular pattern release

  • Text
  • PDF
Abstract

Chronic beryllium disease (CBD) is a metal hypersensitivity/autoimmune disease in which damage-associated molecular patterns (DAMPs) promote a break in T cell tolerance and expansion of Be2+/self-peptide–reactive CD4+ T cells. In this study, we investigated the mechanism of cell death induced by beryllium particles in alveolar macrophages (AMs) and its impact on DAMP release. We found that phagocytosis of Be led to AM cell death independent of caspase, receptor-interacting protein kinases 1 and 3, or ROS activity. Before cell death, Be-exposed AMs secreted TNF-α that boosted intracellular stores of IL-1α followed by caspase-8–dependent fragmentation of DNA. IL-1α and nucleosomal DNA were subsequently released from AMs upon loss of plasma membrane integrity. In contrast, necrotic AMs released only unfragmented DNA and necroptotic AMs released only IL-1α. In mice exposed to Be, TNF-α promoted release of DAMPs and was required for the mobilization of immunogenic DCs, the expansion of Be-reactive CD4+ T cells, and pulmonary inflammation in a mouse model of CBD. Thus, early autocrine effects of particle-induced TNF-α on AMs led to a break in peripheral tolerance. This potentially novel mechanism may underlie the known relationship between fine particle inhalation, TNF-α, and loss of peripheral tolerance in T cell–mediated autoimmune disease and hypersensitivities.

Authors

Morgan K. Collins, Abigail M. Shotland, Morgan F. Wade, Shaikh M. Atif, Denay K. Richards, Manolo Torres-Llompart, Douglas G. Mack, Allison K. Martin, Andrew P. Fontenot, Amy S. McKee

×

Figure 6

TNF-α is required for neutrophil recruitment to the airways and for mobilization of activated pulmonary cDCs to the LDLNs of Be-exposed mice.

Options: View larger image (or click on image) Download as PowerPoint
TNF-α is required for neutrophil recruitment to the airways and for mobi...
B6 mice were injected i.p. with 200 μg isotype control or TNF-α blocking antibody. The next day mice were exposed i.t. to PBS ± 50 μg Be. Eighteen hours later mice were sacrificed. (A and B) BAL cells were analyzed for neutrophil infiltration, and (C and D) LDLNs were analyzed for CD80hi cDCs. (A) Live CD45+ BAL cells were analyzed by flow cytometry for expression of Ly6G and CD11b; gating of Ly6GhiCD11bhi neutrophils is shown on representative samples from each treatment group. Numbers on plots indicate the percentage of (live) CD45+ BAL cells that fall in the neutrophil gate for the samples shown. (B) Total number of neutrophils/BAL is shown. (C) Percentage of live LDLN CD45+ cells that are migratory cDCs (MHCIIhiCD11c+) (upper row) and percentage of migratory cDCs that are CD80hi (lower row) are shown for representative samples in each treatment group. Numbers are the percentage of the gated population that fall into indicated gates for the samples shown. (D) Total migratory cDCs (top) and CD80hi cDCs (bottom) are shown. Data in A and C are from 1 representative of 4 independent experiments. Data in B and D are combined from 4 independent experiments (n = 15 mice/group). Symbols on graphs indicate values from individual mice. Bars indicate means ± SEM in B and medians in D. A 1-way ANOVA was used to test for statistical differences between groups in B. A Kruskal-Wallis test was used to test for statistical differences in D. Statistical P values for select comparisons are indicated as *P < 0.05; **P < 0.01; ***P < 0.001.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts